VXRT News and Press, Vaxart Inc. From 06/25/20

Vaxart (NASDAQ: VXRT ) +25% after-hours after touching a new all-time high $6.48 during today's trade before closing up 96%, after saying it signed an MoU with Attwill Medical Solutions Sterilflow to use AMS' resources for lyophilization development and large scale manufacturing includin...

The war against COVID-19 is intensifying, and investors are placing their bets on which companies they believe will emerge victorious.  Shares of Vaxart (NASDAQ: VXRT) , Inovio Pharmaceuticals (NASDAQ: INO) , and Sorrento Therapeutics (NASDAQ: SRNE) rocketed 96%, 31%, and 14%, re...

Gainers:  Ekso Bionics EKSO  +138% . More news on: Puhui Wealth Investment Management Co., Ltd., Vaxart, Inc., PaySign, Inc., Stocks on the move, , Read more ...

Will July Bring New Highs For These Penny Stocks? The countdown has begun for a few penny stocks . In just 3 more sessions, we will be on the eve of a new month and quarter. While summer months are typically quiet for the stock market, this year’s a bit different. We really didn’...

Puhui Wealth Investment Management (NASDAQ: PHCF ) +70% . More news on: Puhui Wealth Investment Management Co., Ltd., IZEA Worldwide, Inc., Cumulus Media Inc., Stocks on the move, , Read more ...

The silver lining in the persistence of COVID-19 infections, at least for some investors, is the bullish outlook for companies developing vaccines and/or therapies for the respiratory infection. More news on: Vir Biotechnology, Inc., Dynavax Technologies Corporation, Novavax, Inc., Healthc...

Vaxart (NASDAQ: VXRT ) to join Russell 3000 index, effective June 29 at the open. More news on: Vaxart, Inc., Healthcare stocks news, Read more ...

SOUTH SAN FRANCISCO, Calif., June 24, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today tha...

SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today tha...

Vaxart (NASDAQ: VXRT ) appoints Andrei Floroiu as Chief Executive Officer (CEO). More news on: Vaxart, Inc., Healthcare stocks news, Stocks on the move, Read more ...